Abdulla A. Damluji/Linkedin
Aug 12, 2025, 20:14
JACC Meta-Analysis: Anticoagulant Therapy for Atrial Fibrillation Patients Surviving Intracranial Hemorrhage
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared a post on X:
“Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage: A Meta-Analysis of Randomized Trials: JACCJournals.
New publication from our HeartWise research Group led by friend: Michael Nanna in JACC today!”
Read the full article here.
Title: Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage
Authors: Kuan-Yu Chi, Yu Chang, Pei-Lun Lee, Raiza Rossi, Yu-Shiuan Lin, Zafer Akman, Dimitrios Varrias, Abdulla A. Damluji, and Michael G. Nanna
Stay updated on the latest scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia
-
Aug 23, 2026, 16:03Balaji Balagani: Major Causes of Sudden Cardiac Death in Children